Fetuin-A and Risk of Diabetes Independent of Liver Fat Content: The Multi-Ethnic Study of Atherosclerosis

Am J Epidemiol. 2017 Jan 1;185(1):54-64. doi: 10.1093/aje/kww095. Epub 2016 Nov 17.

Abstract

Fetuin-A is a hepatic secretory protein and a novel risk factor for diabetes. However, it remains unclear whether the association between high levels of fetuin-A and diabetes can be attributed to nonalcoholic fatty liver disease. We conducted a case-cohort study among 1,957 subcohort members and 455 incident diabetes cases in the Multi-Ethnic Study of Atherosclerosis, a multicenter US study of Caucasian, African-American, Hispanic, and Chinese-American adults aged 45-84 years. Serum fetuin-A and computed tomography-determined liver fat content were measured from samples collected at baseline (2000-2002). In multivariable Cox proportional hazards models with follow-up through 2012, a higher fetuin-A level was associated with a higher risk of diabetes, with a stronger association among women (for top quartile vs. bottom, hazard ratio (HR) = 3.36, 95% confidence interval (CI): 2.08, 5.44) than among men (HR = 1.47, 95% CI: 0.93, 2.35) (P-heterogeneity = 0.001). Adjustment for liver fat content attenuated these associations slightly (women: HR = 2.61, 95% CI: 1.59, 4.26; men: HR = 1.32, 95% CI: 0.84, 2.08). In this study, we observed a particularly strong association of fetuin-A with diabetes risk in women that could not be explained by liver fat.

Keywords: biological markers; diabetes mellitus; fatty liver disease, non-alcoholic; fetuins.

MeSH terms

  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Asian / statistics & numerical data
  • Biomarkers / blood
  • Black or African American / statistics & numerical data
  • Case-Control Studies
  • Diabetes Mellitus* / blood
  • Diabetes Mellitus* / ethnology
  • Diabetes Mellitus* / etiology
  • Female
  • Hispanic or Latino / statistics & numerical data
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Non-alcoholic Fatty Liver Disease* / blood
  • Non-alcoholic Fatty Liver Disease* / complications
  • Non-alcoholic Fatty Liver Disease* / diagnostic imaging
  • Non-alcoholic Fatty Liver Disease* / ethnology
  • Prevalence
  • Proportional Hazards Models
  • Prospective Studies
  • Risk Factors
  • Sex Distribution
  • Tomography, X-Ray Computed
  • United States / epidemiology
  • White
  • alpha-2-HS-Glycoprotein* / analysis

Substances

  • alpha-2-HS-Glycoprotein
  • Biomarkers